Memorial Sloan-Kettering researchers have discovered how a common bacterium can evolve to become more mobile and easier to get rid of.

This year The Society of MSKCC’s Annual Appeal aims to raise funds to support thyroid cancer research.

A new imaging approach being investigated by Memorial Sloan-Kettering researchers could provide better information about a tumor’s molecular activity, allowing for a more accurate diagnosis.

An earlier post about active surveillance as a management strategy for prostate cancer generated an engaged and meaningful discussion on this blog, especially about the risks of “doing nothing.” Here we take a closer look at the concept of risk.

Hartford Healthcare system in Connecticut has been selected as the first MSK Cancer Alliance member, established to enhance delivery of care, improve patient outcomes, and advance research.

In this Q&A, Memorial Sloan-Kettering chemist Derek Tan discusses why natural products offer inspiration for the development of new drugs.

Memorial Sloan-Kettering clinicians report on a successful first year of using a new procedure to pinpoint and remove small breast cancers.